Skip to main content
Top
Published in: Annals of Surgical Oncology 9/2007

01-09-2007 | Editorial

Heterogenic Loss of BRCA in Breast Cancer: The “Two-Hit” Hypothesis Takes a Hit

Author: Funda Meric-Bernstam, MD

Published in: Annals of Surgical Oncology | Issue 9/2007

Login to get access

Excerpt

Most hereditary cancers have been linked to mutations in tumor suppressor genes. The first tumor suppressor to be cloned was the retinoblastoma gene, RB1. Retinoblastoma occurs in both hereditary and nonhereditary forms. In the hereditary form, most children with an affected parent develop bilateral retinoblastoma; however, some develop unilateral retinoblastoma, and others are not affected themselves, but have an affected child. These findings led to the theory that a single mutation is not sufficient for tumorigenesis. Alfred Knudson hypothesized that hereditary retinoblastoma involves two mutations, one in the germ line, whereas nonhereditary retinoblastoma is due to two somatic mutations, a hypothesis known as Knudson’s “two-hit” hypothesis.1
Literature
2.
go back to reference Collins N, McManus R, Wooster R, et al. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12–13. Oncogene 1995; 10:1673–5PubMed Collins N, McManus R, Wooster R, et al. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12–13. Oncogene 1995; 10:1673–5PubMed
3.
go back to reference Gudmundsson J, Johannesdottir G, Bergthorsson JT, et al. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12–q13. Cancer Res 1995; 55:4830–2PubMed Gudmundsson J, Johannesdottir G, Bergthorsson JT, et al. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12–q13. Cancer Res 1995; 55:4830–2PubMed
4.
go back to reference Neuhausen SL, Marshall CJ. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res 1994; 54:6069–72PubMed Neuhausen SL, Marshall CJ. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res 1994; 54:6069–72PubMed
5.
go back to reference Osorio A, de la Hoya M, Rodriguez-Lopez R, et al. Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int J Cancer 2002; 99:305–9PubMedCrossRef Osorio A, de la Hoya M, Rodriguez-Lopez R, et al. Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int J Cancer 2002; 99:305–9PubMedCrossRef
6.
go back to reference Smith SA, Easton DF, Evans DG, Ponder BA. Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet 1992; 2:128–31PubMedCrossRef Smith SA, Easton DF, Evans DG, Ponder BA. Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet 1992; 2:128–31PubMedCrossRef
7.
go back to reference Chan KY, Ozcelik H, Cheung AN, et al. Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer. Cancer Res 2002; 62:4151–6PubMed Chan KY, Ozcelik H, Cheung AN, et al. Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer. Cancer Res 2002; 62:4151–6PubMed
8.
go back to reference Evers B, Jonkers J. Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects. Oncogene 2006; 25:5885–97PubMedCrossRef Evers B, Jonkers J. Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects. Oncogene 2006; 25:5885–97PubMedCrossRef
9.
go back to reference Mote PA, Leary JA, Avery KA, et al. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A. Genes Chromosomes Cancer 2004; 39:236–48PubMedCrossRef Mote PA, Leary JA, Avery KA, et al. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A. Genes Chromosomes Cancer 2004; 39:236–48PubMedCrossRef
10.
go back to reference Kote-Jarai Z, Matthews L, Osorio A, et al. Accurate prediction of BRCA1 and BRCA2 heterozygous genotype using expression profiling after induced DNA damage. Clin Cancer Res 2006; 12:3896–901PubMedCrossRef Kote-Jarai Z, Matthews L, Osorio A, et al. Accurate prediction of BRCA1 and BRCA2 heterozygous genotype using expression profiling after induced DNA damage. Clin Cancer Res 2006; 12:3896–901PubMedCrossRef
Metadata
Title
Heterogenic Loss of BRCA in Breast Cancer: The “Two-Hit” Hypothesis Takes a Hit
Author
Funda Meric-Bernstam, MD
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 9/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-007-9379-7

Other articles of this Issue 9/2007

Annals of Surgical Oncology 9/2007 Go to the issue